These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12493968)

  • 1. Accessory findings on F-18 FDG positron emission tomography in bronchogenic carcinoma.
    M Herder GJ; Welling A; De Winter GV; Comans EF; Hoekstra OS
    Clin Nucl Med; 2003 Jan; 28(1):58-9. PubMed ID: 12493968
    [No Abstract]   [Full Text] [Related]  

  • 2. Positron emission tomography in lung cancer.
    Lowe VJ; Naunheim KS
    Ann Thorac Surg; 1998 Jun; 65(6):1821-9. PubMed ID: 9647121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of F-18-fluorodeoxyglucose positron emission tomography after induction therapy of locally advanced bronchogenic carcinoma.
    Hellwig D; Graeter TP; Ukena D; Georg T; Kirsch CM; Schäfers HJ
    J Thorac Cardiovasc Surg; 2004 Dec; 128(6):892-9. PubMed ID: 15573074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidental bronchogenic cyst detected on F-18 FDG positron emission tomography.
    Sala E; Coulden R
    Clin Nucl Med; 2004 Aug; 29(8):494-5. PubMed ID: 15249827
    [No Abstract]   [Full Text] [Related]  

  • 5. [18F-FDG PET/CT in paraneoplastic osteoarthropathy].
    Pauls S; Krüger S; Mottaghy FM
    Rofo; 2007 Jan; 179(1):80-2. PubMed ID: 17243205
    [No Abstract]   [Full Text] [Related]  

  • 6. Bronchogenic carcinoma associated with rheumatoid arthritis: role of FDG-PET scans.
    Rodríguez P; Romero T; Rodríguez de Castro F; Hussein M; Freixinet J
    Rheumatology (Oxford); 2006 Mar; 45(3):359-60. PubMed ID: 16436491
    [No Abstract]   [Full Text] [Related]  

  • 7. [F-18 fluorodeoxyglucose positron emission tomography in lung lesions].
    Peschina W
    Wien Med Wochenschr; 2002; 152(11-12):265-8. PubMed ID: 12138653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mediastinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopy.
    Graeter TP; Hellwig D; Hoffmann K; Ukena D; Kirsch CM; Schäfers HJ
    Ann Thorac Surg; 2003 Jan; 75(1):231-5; discussion 235-6. PubMed ID: 12537221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction to clinical positron emission tomography.
    Agress H
    N J Med; 2000 Oct; 97(10):25-30. PubMed ID: 11064564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combined functional and morphological imaging with PET/CT systems].
    Kaim AH; von Schulthess GK
    Praxis (Bern 1994); 2003 Feb; 92(6):225-7. PubMed ID: 12645384
    [No Abstract]   [Full Text] [Related]  

  • 11. Thallium and FDG uptake by atelectasis with bronchogenic carcinoma.
    Kawabe J; Okamura T; Shakudo M; Koyama K; Wanibuchi H; Shimonishi Y; Ochi H; Yamada R
    Ann Nucl Med; 1999 Aug; 13(4):273-6. PubMed ID: 10510886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [18F] 3-deoxy-3'-fluorothymidine positron emission tomography: alternative or diagnostic adjunct to 2-[18f]-fluoro-2-deoxy-D-glucose positron emission tomography in the workup of suspicious central focal lesions?
    Halter G; Buck AK; Schirrmeister H; Wurziger I; Liewald F; Glatting G; Neumaier B; Sunder-Plassmann L; Reske SN; Hetzel M
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1093-9. PubMed ID: 15052207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of pulmonary nodules and mediastinal staging of bronchogenic carcinoma with F-18 fluorodeoxyglucose positron emission tomography.
    Hagberg RC; Segall GM; Stark P; Burdon TA; Pompili MF
    Eur J Cardiothorac Surg; 1997 Jul; 12(1):92-7. PubMed ID: 9262087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography detection of metastatic penile squamous cell carcinoma.
    Ravizzini GC; Wagner M; Borges-Neto S
    J Urol; 2001 May; 165(5):1633-4. PubMed ID: 11342941
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of (18)F-FDG PET/CT for evaluation of metastatic mediastinal lymph nodes in patients with lung squamous-cell carcinoma or adenocarcinoma.
    Lu P; Sun Y; Sun Y; Yu L
    Lung Cancer; 2014 Jul; 85(1):53-8. PubMed ID: 24792334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CT-MIBI image fusion: transmission and emission tomography for localization of bronchogenic carcinoma and nodal metastasis.
    Sharma R; Bhatnagar P; Mondal A; Sawroop K; Datta M; Kashyap R
    Clin Nucl Med; 2006 Jun; 31(6):355-6. PubMed ID: 16714901
    [No Abstract]   [Full Text] [Related]  

  • 17. 18-F fluorodeoxyglucose positron emission tomography indicating unsuspected infections in two patients with dermatomyositis.
    Bachmeyer C; Kerrou K; Chosidow O; Frances C; Montravers F
    Clin Exp Dermatol; 2009 Dec; 34(8):e769-71. PubMed ID: 20055842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staging non-small cell lung cancer with whole-body PET.
    Marom EM; McAdams HP; Erasmus JJ; Goodman PC; Culhane DK; Coleman RE; Herndon JE; Patz EF
    Radiology; 1999 Sep; 212(3):803-9. PubMed ID: 10478250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography, bronchogenic carcinoma, and the adrenals.
    Lamki LM
    AJR Am J Roentgenol; 1997 May; 168(5):1361-2. PubMed ID: 9129445
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer.
    Nakagawa M; Hara M; Sakurai K; Ozawa Y; Mizuno A; Tamaki T; Nishio M; Shibamoto Y
    Acta Radiol; 2009 Jul; 50(6):638-44. PubMed ID: 19492198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.